Xconomy National

Archives

by in

Entry	Author	Date	Location
Potential Treatment for Degenerative Eye Diseases Developed at Wayne State	Sarah Schmid	12/22/11	Detroit
Regeneron Debuts Eye Drug, as Rivals Race to Grab Share of Hot Market	Arlene Weintraub	12/01/11	New York
Regeneron Wins FDA Approval of Drug for Leading Cause of Blindness in Elderly	Luke Timmerman	11/18/11	New York
RetroSense Therapeutics Licenses Vision Restoration Technology From Wayne State	Sarah Schmid	11/01/11	Detroit
Regeneron’s AMD Drug Gets Priority Review With FDA	Arlene Weintraub	04/18/11	New York
ReVision Planning Late-Stage Trial Next Year for Macular Degeneration Drug	Bruce V. Bigelow	10/18/10	San Diego
San Diego’s ReVision Therapeutics, Founded in April, Takes on Development of Drug Candidate for Age-Related Blindness	Bruce V. Bigelow	08/31/10	San Diego
Taligen Collects $10M For Focus on Rare Diseases	Ryan McBride	08/23/10	Boston
Valocor Therapeutics, a QLT Spinoff, Envisions Safe Anti-Acne Drug and More	Luke Timmerman	05/26/10	Seattle
Acucela Gets FDA Fast Track	Luke Timmerman	03/17/10	Seattle
Sequenom Gets Rights to Genetic Test for Vision Disorder	Bruce V. Bigelow	02/09/10	San Diego
Dendreon’s New Operations Man, Acucela Enters Fast Growth Phase, JP Morgan Recap, & More Seattle-Area Life Sciences News	Luke Timmerman	01/21/10	Seattle
Acucela Enters Fast-Growth Phase As Macular Degeneration Drug Advances to Key Trial	Luke Timmerman	01/20/10	Seattle
Top Five Biotech Innovations of the 2000s	Jay Lichter	12/31/09	San Diego
Lpath, a Developer of Lipid-Targeting Drugs, Nears a Fork in the Road	Denise Gellene	06/17/09	San Diego
Dendreon’s Hiring Binge, Calistoga’s Venture Round, ZymoGenetics Unloads Drugs, & More Seattle-Area Life Sciences News	Luke Timmerman	05/07/09	Seattle
Acucela Drug for Macular Degeneration Passes Early Safety Test	Luke Timmerman	05/06/09	Seattle
Genzyme Gene Therapy Fails To Help People with Leg Disease Walk Longer	Luke Timmerman	03/31/09	Boston
Sticking to its Guns with Gene Therapy, Genzyme To Present Key Findings Within Days	Luke Timmerman	03/25/09	Boston
Acucela Strikes Deal With Otsuka Pharmaceutical to Develop Drug for Eye Disease	Luke Timmerman	09/04/08	Seattle
Taligen CEO Aims to Develop Drugs For Inflammatory Diseases, Build Company in Cambridge	Luke Timmerman	08/14/08	Boston
Page 1 of 1